Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking
- PMID: 2334904
Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking
Abstract
Levels of 4-aminobiphenyl-hemoglobin adducts in smokers of blonde (flue-cured) and black (air-cured) tobacco have been found to be proportional to bladder cancer risk. In addition, risk of bladder cancer due to exposure to occupational carcinogens is elevated in genetically determined slow acetylators. In this study of normal male volunteers, 4-aminobiphenyl-hemoglobin adducts were found to be related to both the quantity and the type of tobacco smoked, as well as to the acetylator phenotype (independently of smoking habits). The demonstration that both the genetically determined slow acetylator phenotype and tobacco smoking are independently associated with levels of the carcinogen 4-aminobiphenyl in adducted hemoglobin suggests a single mechanism to explain the contribution of genetic susceptibility and environmental exposure in bladder carcinogenesis.
Similar articles
-
Molecular epidemiology of bladder cancer.Ann Ist Super Sanita. 1996;32(1):21-7. Ann Ist Super Sanita. 1996. PMID: 8967722 Review.
-
Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.Cancer Epidemiol Biomarkers Prev. 1996 Sep;5(9):693-8. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8877060
-
N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.Cancer Epidemiol Biomarkers Prev. 2000 Jun;9(6):619-23. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10868698
-
Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.J Natl Cancer Inst. 1990 Dec 5;82(23):1826-31. doi: 10.1093/jnci/82.23.1826. J Natl Cancer Inst. 1990. PMID: 2250298
-
Epidemiological models of carcinogenesis: the example of bladder cancer.Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):149-53. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1306098 Review.
Cited by
-
MDA in plasma as a biomarker of exposure to pyrolysed MDI-based polyurethane: correlations with estimated cumulative dose and genotype for N-acetylation.Int Arch Occup Environ Health. 1996;68(3):165-9. doi: 10.1007/BF00381626. Int Arch Occup Environ Health. 1996. PMID: 8919844
-
N-alkylvaline levels in globin as a new type of biomarker in risk assessment of alkylating agents.Int Arch Occup Environ Health. 1996;68(6):519-30. doi: 10.1007/BF00377881. Int Arch Occup Environ Health. 1996. PMID: 8891797
-
Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.Environ Health Perspect. 1992 Nov;98:167-78. doi: 10.1289/ehp.9298167. Environ Health Perspect. 1992. PMID: 1486846 Free PMC article. Review.
-
Utilization of biomarker data for clinical and environmental intervention.Environ Health Perspect. 1996 Oct;104 Suppl 5(Suppl 5):921-5. doi: 10.1289/ehp.96104s5921. Environ Health Perspect. 1996. PMID: 8933035 Free PMC article. Review.
-
Protein adduct biomarkers: state of the art.Environ Health Perspect. 1996 Oct;104 Suppl 5(Suppl 5):879-82. doi: 10.1289/ehp.96104s5879. Environ Health Perspect. 1996. PMID: 8933029 Free PMC article. Review.